PURPOSE OF REVIEW: Many men and women living with HIV and their uninfected partners attempt to conceive children. HIV-prevention science can be applied to reduce sexual transmission risk while respecting couples' reproductive goals. Here we discuss antiretrovirals as prevention in the context of safer conception for HIV-serodiscordant couples. RECENT FINDINGS: Antiretroviral therapy (ART) for the infected partner and pre-exposure prophylaxis (PrEP) for the uninfected partner reduce the risk of heterosexual HIV transmission. Several demonstration projects suggest the feasibility and acceptability of antiretroviral (ARV)s as periconception HIV-prevention for HIV-serodiscordant couples. The application of ARVs to periconception risk reduction may be limited by adherence. SUMMARY: For male-infected (M+F-) couples who cannot access sperm processing and female-infected (F+M-) couples unwilling to carry out insemination without intercourse, ART for the infected partner, PrEP for the uninfected partner, combined with treatment for sexually transmitted infections, sex limited to peak fertility, and medical male circumcision (for F+M couples) provide excellent, well tolerated options for reducing the risk of periconception HIV sexual transmission.
PURPOSE OF REVIEW: Many men and women living with HIV and their uninfected partners attempt to conceive children. HIV-prevention science can be applied to reduce sexual transmission risk while respecting couples' reproductive goals. Here we discuss antiretrovirals as prevention in the context of safer conception for HIV-serodiscordant couples. RECENT FINDINGS: Antiretroviral therapy (ART) for the infected partner and pre-exposure prophylaxis (PrEP) for the uninfected partner reduce the risk of heterosexual HIV transmission. Several demonstration projects suggest the feasibility and acceptability of antiretroviral (ARV)s as periconception HIV-prevention for HIV-serodiscordant couples. The application of ARVs to periconception risk reduction may be limited by adherence. SUMMARY: For male-infected (M+F-) couples who cannot access sperm processing and female-infected (F+M-) couples unwilling to carry out insemination without intercourse, ART for the infected partner, PrEP for the uninfected partner, combined with treatment for sexually transmitted infections, sex limited to peak fertility, and medical male circumcision (for F+M couples) provide excellent, well tolerated options for reducing the risk of periconception HIV sexual transmission.
Authors: Norma C Ware; Monique A Wyatt; Jessica E Haberer; Jared M Baeten; Alexander Kintu; Christina Psaros; Steven Safren; Elioda Tumwesigye; Connie L Celum; David R Bangsberg Journal: J Acquir Immune Defic Syndr Date: 2012-04-15 Impact factor: 3.731
Authors: Kristine B Patterson; Heather A Prince; Eric Kraft; Amanda J Jenkins; Nicholas J Shaheen; James F Rooney; Myron S Cohen; Angela D M Kashuba Journal: Sci Transl Med Date: 2011-12-07 Impact factor: 17.956
Authors: Nelly R Mugo; Renee Heffron; Deborah Donnell; Anna Wald; Edwin O Were; Helen Rees; Connie Celum; James N Kiarie; Craig R Cohen; Kayitesi Kayintekore; Jared M Baeten Journal: AIDS Date: 2011-09-24 Impact factor: 4.177
Authors: Timothy B Hallett; Jared M Baeten; Renee Heffron; Ruanne Barnabas; Guy de Bruyn; Íde Cremin; Sinead Delany; Geoffrey P Garnett; Glenda Gray; Leigh Johnson; James McIntyre; Helen Rees; Connie Celum Journal: PLoS Med Date: 2011-11-15 Impact factor: 11.069
Authors: Reuben Granich; James G Kahn; Rod Bennett; Charles B Holmes; Navneet Garg; Celicia Serenata; Miriam Lewis Sabin; Carla Makhlouf-Obermeyer; Christina De Filippo Mack; Phoebe Williams; Louisa Jones; Caoimhe Smyth; Kerry A Kutch; Lo Ying-Ru; Marco Vitoria; Yves Souteyrand; Siobhan Crowley; Eline L Korenromp; Brian G Williams Journal: PLoS One Date: 2012-02-13 Impact factor: 3.240
Authors: Gaudensia Mutua; Eduard Sanders; Peter Mugo; Omu Anzala; Jessica E Haberer; David Bangsberg; Burc Barin; James F Rooney; David Mark; Paramesh Chetty; Patricia Fast; Frances H Priddy Journal: PLoS One Date: 2012-04-12 Impact factor: 3.240
Authors: Mahlet Atakilt Woldetsadik; Kathy Goggin; Vincent S Staggs; Rhoda K Wanyenze; Jolly Beyeza-Kashesya; Deborah Mindry; Sarah Finocchario-Kessler; Sarah Khanakwa; Glenn J Wagner Journal: AIDS Behav Date: 2016-06
Authors: Sheree R Schwartz; Jean Bassett; Ian Sanne; Rebecca Phofa; Nompumelelo Yende; Annelies Van Rie Journal: AIDS Date: 2014-07 Impact factor: 4.177
Authors: Sheree R Schwartz; Nora West; Rebecca Phofa; Nompumelelo Yende; Ian Sanne; Jean Bassett; Annelies Van Rie Journal: Int J STD AIDS Date: 2015-09-18 Impact factor: 1.359
Authors: Paul Kawale; Deborah Mindry; Stephanie Stramotas; Peter Chilikoh; Ann Phoya; Katherine Henry; David Elashoff; Perry Jansen; Risa Hoffman Journal: AIDS Care Date: 2013-11-06